AUM Cardiovascular Wins Gold in Best in Biz Awards 2017
November 30, 2017
AUM Cardiovascular has been named a gold winner in Best New Product of the Year – Healthcare in Best in Biz Awards, the only independent business awards program judged each year by prominent editors and reporters from top-tier publications in North America.
In 2017 AUM Cardiovascular received FDA approval for the revolutionary diagnostic heart device – CADence™. The CADence System is designed as a tool to assess cardiovascular health through an innovative, non-invasive, zero-radiation test. The device uses sophisticated acoustic detection, wireless electrocardiogram (EKG) and analysis — a very exciting new method that looks for normal, pathological and physiological murmurs.
The CADence handheld device collects heart sound data on four locations of the patient’s chest. A tablet with an app custom built to work with AT&T’s wireless services receives data from the device. The AT&T Global SIM card sends the data in a highly secure manner to AUM’s secure server for analysis. The proprietary technology is based on combining ultra-sensitive targeted frequency acoustic wave, ECG measurement and sophisticated computer algorithms. This technology provides a tool for clinicians to assess blood flow changes associated with normal, pathological and physiological murmurs – including intracoronary, cardiac shunts, congestive heart failure, heart valve abnormalities, additional and split heart sounds and findings associated with cardiomyopathy. AUM is currently seeking FDA clearance as a coronary artery disease diagnostic device.
